Vimarsana
Biggest News Aggregation in the World

Page 4 - Intersect Ent Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intersect Ent Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intersect Ent Inc Today - Breaking & Trending Today

Sinus Dilation Devices Market to Reach US$ 4.7 Bn by 2031, Finds TMR - Vimarsana News

Sinus Dilation Devices Market to Reach US$ 4.7 Bn by 2031, Finds TMR

/PRNewswire/ -- Need for reducing the prevalence of chronic sinusitis has expanded the scope of commercialization of minimally invasive devices for sinusitis...

Transparency Market Research: Sinus Dilation Devices Market to Reach US$ 4.7 Bn by 2031, Finds TMR - Vimarsana News

Transparency Market Research: Sinus Dilation Devices Market to Reach US$ 4.7 Bn by 2031, Finds TMR

Patient's increasing push toward sinus balloon dilation procedures (BSPs) due to better surgical outcomes propelling lucrative opportunities in sinus dilation devices market; rising numbers

Medtronic acquires Intersect ENT, sells Fiagon to Hemostasis LLC as required by FTC | Knobbe Martens - Vimarsana News

Medtronic acquires Intersect ENT, sells Fiagon to Hemostasis LLC as required by FTC | Knobbe Martens

On May 13, 2022, Medtronic, Inc. announced that it completed the acquisition of Intersect ENT, Inc. The transaction was only able to gain approval of the Federal Trade Commission (FTC)...

FTC Orders Medtronic to Divest Subsidiary Before Acquisition to Prevent Concentration in ENT Market - Vimarsana News

FTC Orders Medtronic to Divest Subsidiary Before Acquisition to Prevent Concentration in ENT Market

On Tuesday, the Federal Trade Commission (FTC) issued an order requiring medical device company Medtronic, Inc. to divest Fiagon, a subsidiary of

Intersect ENT, Inc. (NASDAQ:XENT) Short Interest Up 41.4% in April - Vimarsana News

Intersect ENT, Inc. (NASDAQ:XENT) Short Interest Up 41.4% in April

Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,870,000 shares, a growth of 41.4% from the March 31st total of 2,030,000 shares. Currently, 8.7% of the shares of the company are short […]